Johnson & Johnson scores 41/100 (Below expectations) on SINK's independent climate assessment — scored from public data only, no company payment can change a number. Last verified May 2026.
That places Johnson & Johnson joint 334th of 809 companies scored, and 11th of 15 in Healthcare / Pharmaceuticals.
Johnson & Johnson reports comprehensive climate data with third-party verification but stalls on emissions reduction where it matters most: Scope 3 emissions are flat year-on-year despite revenue growth, and net-zero validation lapsed without revalidation. Nature and biodiversity impact remains largely unquantified. Systemic governance failures evident in 90,000+ talc litigation cases and deforestation-linked palm sourcing.
Every supplier scored from public evidence like this, ranked, in 48 hours. No questionnaires, and your suppliers never know.
This score uses public evidence only. Challenge any question for free, or ask for a human review of evidence you haven't published.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleStrongest on Carbon Footprint — Operations and Energy Source (7/10, 7/10). Weakest on Nature & Biodiversity Impact and Controversies & Red Flags (3/10, 4/10).
12 sources used in this assessment. All publicly available. Each row shows which rubric questions it informed.
8 of 12 sources are third-party verified or public record.
If you believe a source has been misread or a newer version exists, submit a challenge.
Where Johnson & Johnson sits among healthcare / pharmaceuticals peers.
Among the 15 major healthcare / pharmaceuticals brands we've scored, Johnson & Johnson sits 11th of 15.
Score history begins 8 February 2026.
As Johnson & Johnson's score updates, the trajectory will appear here.
This score is not currently being contested.
Every challenge is published. We'd rather be corrected than wrong — that's the whole point.
No challenges submitted yet. If you have evidence that contradicts this score, you can challenge any question above — cite a public source and we'll review it.
Johnson & Johnson is a diversified healthcare company headquartered in New Brunswick, New Jersey, operating across pharmaceuticals, medical devices, and consumer health. Founded in 1886, J&J is one of the world's largest healthcare conglomerates with 136,400 employees and FY2024 revenue of $88.8 billion. The company ranks in the top tier by scale but faces persistent product liability and supply chain governance challenges.
Peer pharmaceutical manufacturer facing similar supply-chain emissions stalls and regulatory compliance pressures.
View breakdown →Comparable healthcare multinational with higher renewable energy penetration and lower nature-related governance gaps.
View breakdown →Consumer-health peer with stronger biodiversity quantification but comparable litigation and supply-chain complexity.
View breakdown →Email alerts when a rubric question is verified, a challenge is resolved, or the overall score changes.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Checking your suppliers?
Get your list scored in 48 hours →Been scored?
See what's behind your number →Nobody can pay us to change a number.